Ind-Swift launches cardio diabetic & antibiotic products in Qatar
3rd Jun 2022

Expanding its reach in the markets of GCC Countries, Ind-Swift has launched a range of cardio diabetic & antibiotic products in the markets of Qatar. The launch event was held in partnership with WellcareGroup .Wellcare Group is the authorized distributor of Ind-Swift’s products in Qatar & is one of the leading healthcare distribution companies in Qatar and represents more than 100 brands with a distribution lineup of customers from leading government and semi government establishments, private hospital and medical centres, pharmacies and other institutions.

In UAE, currently, Ind-Swift has a total of 6 products (including line extensions) which are marketed by a dedicated team of 4 MRs and a National Sales Manager. Ind-Swift has major expansion plans to increase the product line to 23 products for UAE market. With 27 products (including line extensions) under registration in Oman with its partner AlHasar Pharmacy, Oman is an important market amongst the GCC. With current 8 products and tie up with its distributor-Wellcare group, Qatar is emerging as a potential focus market for Ind-Swift. Apart from these countries, Ind-Swift is also supplying its products in market of Iraq & Yemen and making available quality products at an affordable price to customers.

Ind-Swift is a north India based pharmaceutical company.